Narrowing in on Cardiovascular Disease: The Atheroprotective Role of Peroxisome Proliferator–Activated Receptor γ

Peroxisome proliferator–activated receptor γ (PPAR γ ) is a nuclear receptor that has been suggested to play protective roles in the pathogenesis of diseases that are characterized by chronic inflammation, such as atherosclerosis. The study of nuclear receptors, including PPAR γ , has led to the dis...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Trends in cardiovascular medicine 2008-02, Vol.18 (2), p.39-44
Hauptverfasser: Gerry, Jon M, Pascual, Gabriel
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 44
container_issue 2
container_start_page 39
container_title Trends in cardiovascular medicine
container_volume 18
creator Gerry, Jon M
Pascual, Gabriel
description Peroxisome proliferator–activated receptor γ (PPAR γ ) is a nuclear receptor that has been suggested to play protective roles in the pathogenesis of diseases that are characterized by chronic inflammation, such as atherosclerosis. The study of nuclear receptors, including PPAR γ , has led to the discovery of anti-inflammatory processes that are collectively known as transrepression. In this review, we will highlight some of the mechanisms of PPAR γ -mediated transrepression that have surfaced throughout the past decade. We will also discuss the existing evidence for an atheroprotective role of PPARγ as a repressor of inflammatory genes and as a key determinant of distinct monocyte-derived subpopulations that may serve an anti-inflammatory, homeostatic role in atherogenesis.
doi_str_mv 10.1016/j.tcm.2007.12.001
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_70345654</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S1050173807002575</els_id><sourcerecordid>70345654</sourcerecordid><originalsourceid>FETCH-LOGICAL-c406t-eb19c1e48e46d85d24bcf5a487b8113a3637f4e983c8025e8822042bf9c443543</originalsourceid><addsrcrecordid>eNp9kUFu1DAUhiMEoqVwADbIK3ZJ34udxAMS0miAglRBVcracpwX6iGJp3Yy0F3v0KP0HhyCk9RhRkJiwcrW0_f_sr-XJM8RMgQsj9fZaPosB6gyzDMAfJAcoqx4mpdYPIx3KCDFisuD5EkIawAoRYmPkwOUHCQu-GEyftLeux92-MbswNzAVto31m11MFOnPXtrA-lAr9jFJbHleEnebbwbyYx2S-zcdcRcy87i-KcNrid25l1nW_J6dP73ze1yBvVIDTsnQ5s4ZL_uniaPWt0FerY_j5Kv799drD6kp59PPq6Wp6kRUI4p1bgwSEKSKBtZNLmoTVtoIataInLNS161ghaSGwl5QVLmOYi8bhdGCF4IfpS83PXGJ19NFEbV22Co6_RAbgqqAi6K8g-IO9B4F4KnVm287bW_VghqVq3WKqpWs2qFuYqqY-bFvnyqe2r-JvZuI_B6B1D84taSV8FYGgw11kd_qnH2v_Vv_kmbzg7W6O47XVNYu8kP0Z1CFWJAfZl3Pa8aKoguqoLfA-ZUpkg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>70345654</pqid></control><display><type>article</type><title>Narrowing in on Cardiovascular Disease: The Atheroprotective Role of Peroxisome Proliferator–Activated Receptor γ</title><source>MEDLINE</source><source>ScienceDirect Freedom Collection (Elsevier)</source><creator>Gerry, Jon M ; Pascual, Gabriel</creator><creatorcontrib>Gerry, Jon M ; Pascual, Gabriel</creatorcontrib><description>Peroxisome proliferator–activated receptor γ (PPAR γ ) is a nuclear receptor that has been suggested to play protective roles in the pathogenesis of diseases that are characterized by chronic inflammation, such as atherosclerosis. The study of nuclear receptors, including PPAR γ , has led to the discovery of anti-inflammatory processes that are collectively known as transrepression. In this review, we will highlight some of the mechanisms of PPAR γ -mediated transrepression that have surfaced throughout the past decade. We will also discuss the existing evidence for an atheroprotective role of PPARγ as a repressor of inflammatory genes and as a key determinant of distinct monocyte-derived subpopulations that may serve an anti-inflammatory, homeostatic role in atherogenesis.</description><identifier>ISSN: 1050-1738</identifier><identifier>EISSN: 1873-2615</identifier><identifier>DOI: 10.1016/j.tcm.2007.12.001</identifier><identifier>PMID: 18308193</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Atherosclerosis - physiopathology ; Cardiovascular ; Humans ; Inflammation ; Macrophage Activation ; Macrophages - physiology ; PPAR gamma - physiology ; Receptors, Cytoplasmic and Nuclear - genetics ; Receptors, Cytoplasmic and Nuclear - physiology ; Transcription Factors - physiology</subject><ispartof>Trends in cardiovascular medicine, 2008-02, Vol.18 (2), p.39-44</ispartof><rights>2008</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c406t-eb19c1e48e46d85d24bcf5a487b8113a3637f4e983c8025e8822042bf9c443543</citedby><cites>FETCH-LOGICAL-c406t-eb19c1e48e46d85d24bcf5a487b8113a3637f4e983c8025e8822042bf9c443543</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.tcm.2007.12.001$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/18308193$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Gerry, Jon M</creatorcontrib><creatorcontrib>Pascual, Gabriel</creatorcontrib><title>Narrowing in on Cardiovascular Disease: The Atheroprotective Role of Peroxisome Proliferator–Activated Receptor γ</title><title>Trends in cardiovascular medicine</title><addtitle>Trends Cardiovasc Med</addtitle><description>Peroxisome proliferator–activated receptor γ (PPAR γ ) is a nuclear receptor that has been suggested to play protective roles in the pathogenesis of diseases that are characterized by chronic inflammation, such as atherosclerosis. The study of nuclear receptors, including PPAR γ , has led to the discovery of anti-inflammatory processes that are collectively known as transrepression. In this review, we will highlight some of the mechanisms of PPAR γ -mediated transrepression that have surfaced throughout the past decade. We will also discuss the existing evidence for an atheroprotective role of PPARγ as a repressor of inflammatory genes and as a key determinant of distinct monocyte-derived subpopulations that may serve an anti-inflammatory, homeostatic role in atherogenesis.</description><subject>Atherosclerosis - physiopathology</subject><subject>Cardiovascular</subject><subject>Humans</subject><subject>Inflammation</subject><subject>Macrophage Activation</subject><subject>Macrophages - physiology</subject><subject>PPAR gamma - physiology</subject><subject>Receptors, Cytoplasmic and Nuclear - genetics</subject><subject>Receptors, Cytoplasmic and Nuclear - physiology</subject><subject>Transcription Factors - physiology</subject><issn>1050-1738</issn><issn>1873-2615</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2008</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kUFu1DAUhiMEoqVwADbIK3ZJ34udxAMS0miAglRBVcracpwX6iGJp3Yy0F3v0KP0HhyCk9RhRkJiwcrW0_f_sr-XJM8RMgQsj9fZaPosB6gyzDMAfJAcoqx4mpdYPIx3KCDFisuD5EkIawAoRYmPkwOUHCQu-GEyftLeux92-MbswNzAVto31m11MFOnPXtrA-lAr9jFJbHleEnebbwbyYx2S-zcdcRcy87i-KcNrid25l1nW_J6dP73ze1yBvVIDTsnQ5s4ZL_uniaPWt0FerY_j5Kv799drD6kp59PPq6Wp6kRUI4p1bgwSEKSKBtZNLmoTVtoIataInLNS161ghaSGwl5QVLmOYi8bhdGCF4IfpS83PXGJ19NFEbV22Co6_RAbgqqAi6K8g-IO9B4F4KnVm287bW_VghqVq3WKqpWs2qFuYqqY-bFvnyqe2r-JvZuI_B6B1D84taSV8FYGgw11kd_qnH2v_Vv_kmbzg7W6O47XVNYu8kP0Z1CFWJAfZl3Pa8aKoguqoLfA-ZUpkg</recordid><startdate>20080201</startdate><enddate>20080201</enddate><creator>Gerry, Jon M</creator><creator>Pascual, Gabriel</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20080201</creationdate><title>Narrowing in on Cardiovascular Disease: The Atheroprotective Role of Peroxisome Proliferator–Activated Receptor γ</title><author>Gerry, Jon M ; Pascual, Gabriel</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c406t-eb19c1e48e46d85d24bcf5a487b8113a3637f4e983c8025e8822042bf9c443543</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2008</creationdate><topic>Atherosclerosis - physiopathology</topic><topic>Cardiovascular</topic><topic>Humans</topic><topic>Inflammation</topic><topic>Macrophage Activation</topic><topic>Macrophages - physiology</topic><topic>PPAR gamma - physiology</topic><topic>Receptors, Cytoplasmic and Nuclear - genetics</topic><topic>Receptors, Cytoplasmic and Nuclear - physiology</topic><topic>Transcription Factors - physiology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Gerry, Jon M</creatorcontrib><creatorcontrib>Pascual, Gabriel</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Trends in cardiovascular medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Gerry, Jon M</au><au>Pascual, Gabriel</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Narrowing in on Cardiovascular Disease: The Atheroprotective Role of Peroxisome Proliferator–Activated Receptor γ</atitle><jtitle>Trends in cardiovascular medicine</jtitle><addtitle>Trends Cardiovasc Med</addtitle><date>2008-02-01</date><risdate>2008</risdate><volume>18</volume><issue>2</issue><spage>39</spage><epage>44</epage><pages>39-44</pages><issn>1050-1738</issn><eissn>1873-2615</eissn><abstract>Peroxisome proliferator–activated receptor γ (PPAR γ ) is a nuclear receptor that has been suggested to play protective roles in the pathogenesis of diseases that are characterized by chronic inflammation, such as atherosclerosis. The study of nuclear receptors, including PPAR γ , has led to the discovery of anti-inflammatory processes that are collectively known as transrepression. In this review, we will highlight some of the mechanisms of PPAR γ -mediated transrepression that have surfaced throughout the past decade. We will also discuss the existing evidence for an atheroprotective role of PPARγ as a repressor of inflammatory genes and as a key determinant of distinct monocyte-derived subpopulations that may serve an anti-inflammatory, homeostatic role in atherogenesis.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>18308193</pmid><doi>10.1016/j.tcm.2007.12.001</doi><tpages>6</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1050-1738
ispartof Trends in cardiovascular medicine, 2008-02, Vol.18 (2), p.39-44
issn 1050-1738
1873-2615
language eng
recordid cdi_proquest_miscellaneous_70345654
source MEDLINE; ScienceDirect Freedom Collection (Elsevier)
subjects Atherosclerosis - physiopathology
Cardiovascular
Humans
Inflammation
Macrophage Activation
Macrophages - physiology
PPAR gamma - physiology
Receptors, Cytoplasmic and Nuclear - genetics
Receptors, Cytoplasmic and Nuclear - physiology
Transcription Factors - physiology
title Narrowing in on Cardiovascular Disease: The Atheroprotective Role of Peroxisome Proliferator–Activated Receptor γ
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T06%3A15%3A13IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Narrowing%20in%20on%20Cardiovascular%20Disease:%20The%20Atheroprotective%20Role%20of%20Peroxisome%20Proliferator%E2%80%93Activated%20Receptor%20%CE%B3&rft.jtitle=Trends%20in%20cardiovascular%20medicine&rft.au=Gerry,%20Jon%20M&rft.date=2008-02-01&rft.volume=18&rft.issue=2&rft.spage=39&rft.epage=44&rft.pages=39-44&rft.issn=1050-1738&rft.eissn=1873-2615&rft_id=info:doi/10.1016/j.tcm.2007.12.001&rft_dat=%3Cproquest_cross%3E70345654%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=70345654&rft_id=info:pmid/18308193&rft_els_id=1_s2_0_S1050173807002575&rfr_iscdi=true